Top Stories
The tool could help identify which patients are most likely to benefit from immunotherapy and stem cell transplantation.
The Avantect test showed strong sensitivity and specificity in patients with multiple risk factors, including type 2 diabetes.
The company emerged from stealth Thursday with undisclosed pre-seed backing from MAVRK Celestia Fund, Kern Venture Group and Digital Neural Infrastructure Holdings.
The smart ring maker raised a $900-million financing in October.
CMR-CLIP was trained on more than 11,000 cardiac MRI studies and outperformed AI systems adapted from broader imaging tasks by more than 35% in some tests.
Conference News
May 22, 2026The nationally-ranked urology department at Hackensack University Medical Center made a major impact at the American Urological Association (AUA) Annual Meeting in Washington, D.C., which ...
Study conducted with Severance Hospital shows whole-genome sequencing-based HRD phenotyping was associated with longer progression-free survival in patients receiving PARP inhibitor maintenance therap...
BOSTON--(BUSINESS WIRE)-- Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced it will showcase data across its portfolio of high-quality comprehensive geno...
MORRISVILLE, N.C.--(BUSINESS WIRE)-- SAGA Diagnostics, a pioneer in ultrasensitive molecular residual disease (MRD) detection and precision oncology, today announced that the company and key collabora...
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) Breakthrough meeting will bring together global oncology professionals in Asia to discuss the latest cancer research advances across ...
